Apoptosis最新文献

筛选
英文 中文
Role of pyroptosis in breast cancer: Molecular mechanisms and therapeutic strategies. 焦亡在乳腺癌中的作用:分子机制和治疗策略。
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-14 DOI: 10.1007/s10495-026-02434-8
Xue-Chun Qu, Jing Zhang, Ke Zhang, Xiao-Han Zhang, Jia-Feng Li, Pei-Hao Sun, Ruo-Yu Xu, Wei-Rong Si, Tie-Shan Teng, Dong-Dong Wu
{"title":"Role of pyroptosis in breast cancer: Molecular mechanisms and therapeutic strategies.","authors":"Xue-Chun Qu, Jing Zhang, Ke Zhang, Xiao-Han Zhang, Jia-Feng Li, Pei-Hao Sun, Ruo-Yu Xu, Wei-Rong Si, Tie-Shan Teng, Dong-Dong Wu","doi":"10.1007/s10495-026-02434-8","DOIUrl":"https://doi.org/10.1007/s10495-026-02434-8","url":null,"abstract":"<p><p>As one of the most prevalent malignancies affecting female populations globally, breast cancer presents major clinical challenges, particularly the emergence of therapeutic resistance and treatment-related toxicities that compromise existing intervention strategies. In recent years, programmed cell death (PCD) has emerged as a pivotal strategy in cancer therapy, with pyroptosis, an inflammatory form of PCD, demonstrating substantial therapeutic potential. This process, which is mediated by Gasdermin family proteins through membrane pore formation and subsequent release of pro-inflammatory cytokines, exerts dual roles in breast cancer progression. This review systematically delineates the classical, non-canonical, and emerging activation pathways of pyroptosis, with particular emphasis on the mechanistic interplay between cancer-associated fibroblasts (CAFs) and pyroptosis, as well as its central function in remodeling the tumor immune microenvironment. We summarize the applications of pyroptosis in biomarker development, molecular target identification, and combinatorial therapeutic regimens, and propose optimization strategies specifically for treatment-resistant subtypes such as triple-negative breast cancer. Finally, we identify future research directions, highlighting key challenges including precise modulation of pyroptotic activity, mitigation of excessive inflammatory responses, and overcoming CAF-mediated therapeutic resistance.</p>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications. 铜质增生在乳腺癌中的作用:分子机制和治疗意义。
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-14 DOI: 10.1007/s10495-026-02456-2
Ke Zhang, Xiao-Han Zhang, Xue-Chun Qu, Jing Zhang, Jia-Feng Li, Pei-Hao Sun, Ruo-Yu Xu, Wei-Rong Si, Qi-Ying Jiang, Dong-Dong Wu
{"title":"The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications.","authors":"Ke Zhang, Xiao-Han Zhang, Xue-Chun Qu, Jing Zhang, Jia-Feng Li, Pei-Hao Sun, Ruo-Yu Xu, Wei-Rong Si, Qi-Ying Jiang, Dong-Dong Wu","doi":"10.1007/s10495-026-02456-2","DOIUrl":"https://doi.org/10.1007/s10495-026-02456-2","url":null,"abstract":"<p><p>Cuproptosis is copper-induced programmed cell death closely linked to malignant tumor phenotypes. This review summarizes the mitochondrial metabolic dysregulation-mediated mechanisms of cuproptosis and its differential regulatory networks across various breast cancer subtypes, focusing on key molecular events such as copper transport, ferredoxin 1, protein aggregation, and disruption of iron‑sulfur clusters. It systematically elaborates cuproptosis-targeted translational strategies for breast cancer. These strategies include nanodelivery systems, combination therapies with radiotherapy/chemotherapy or immunotherapy, small-molecule interventions, and approaches based on natural products. For instance, polyacrylic acid‑modified copper‑manganese‑selenium nanoplatforms achieve synergistic triple‑modal antitumor effects via chemotherapy, cuproptosis activation, and chemodynamic therapy. It highlights the prognostic value of cuproptosis-related coding genes and lncRNAs, and multi-cell-death models integrating cuproptosis, ferroptosis and pyroptosis for risk stratification and drug-resistance prediction. This article stresses breast cancer subtype heterogeneity and the tumor‑microenvironment‑driven resistance to cuproptosis therapy. It also provides new insights into how copper ion therapy reshapes the tumor immune microenvironment and mediates multidrug resistance. Furthermore, it highlights key translational challenges: the lack of cuproptosis‑specific biomarkers, inconsistent bioinformatic‑functional results, and insufficient clinical evidence for copper‑based therapeutics. Finally, the article proposes that future efforts should focus on functional validation, elucidation of signaling pathways, subtype-based therapies, and multicenter verification.</p>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell-type-specific programmed cell death imbalance drives immune checkpoint blockade resistance in microsatellite-stable colorectal cancer 微卫星稳定结直肠癌中细胞类型特异性程序性细胞死亡失衡驱动免疫检查点阻断抵抗
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-11 DOI: 10.1007/s10495-026-02474-0
Jiazhi Yi, Shuyun Wu, Hongxia He
{"title":"Cell-type-specific programmed cell death imbalance drives immune checkpoint blockade resistance in microsatellite-stable colorectal cancer","authors":"Jiazhi Yi,&nbsp;Shuyun Wu,&nbsp;Hongxia He","doi":"10.1007/s10495-026-02474-0","DOIUrl":"10.1007/s10495-026-02474-0","url":null,"abstract":"<div><p>Programmed cell death (PCD) is a metabolically controlled decision point that shapes antitumor immunity, and its dysregulation is increasingly recognized as a central driver of immune‑checkpoint‑blockade (ICB) resistance in microsatellite‑stable (MSS) colorectal cancer (CRC). Mechanistically, this review focuses on the cell-type-specific molecular switches that determine whether PCD drives immunosuppression or immunogenic cell death. In this review, we propose a unified mechanistic framework centered on a dual PCD imbalance: dysregulated tumor microenvironment (TME) metabolism predominantly activates pyroptosis, ferroptosis, and apoptosis in antitumor immune cells—an immunosuppressive outcome that depends on cell type, stimulus, and tissue context—while tumor-intrinsic epigenetic silencing preferentially abolishes necroptosis, cuproptosis, and PANoptosis in tumor cells, blocking DAMP release and de novo T cell priming. Four stromal and immune subsets drive distinct metabolic cascades: cancer‑associated fibroblasts fuel lactate‑mediated dendritic cell pyroptosis and CD8⁺ T cell ferroptosis; tumor‑associated macrophages amplify lipid‑peroxidation‑driven ferroptosis; myeloid‑derived suppressor cells induce T cell apoptosis via amino acid deprivation; and regulatory T cells exploit kynurenine and adenosine signaling to eliminate antitumor lymphocytes. These cellular insults are reinforced by soluble amplifiers (TGF‑β, IL‑10/IL‑35, adenosine) and VEGF‑driven hypoxia, forming a redundant immunosuppressive network. We hypothesize that this dual PCD imbalance—sustained suppressive PCD of antitumor immune cells combined with silenced immunogenic PCD of tumor cells—locks MSS CRC in an immune‑cold state and explains why single‑agent therapies consistently fail. Accordingly, CMS‑stratified combinatorial regimens that concurrently restrain suppressive PCD and awaken immunogenic tumor cell death may be required to overcome ICB resistance. Emerging approaches spanning spatial multi‑omics, gut microbiota targeting, and myeloid checkpoint inhibition provide opportunities to remodel the cold TME and translate this metabolic‑PCD framework into subtype‑tailored precision immunotherapy for MSS CRC. This dual-PCD-imbalance framework is a testable working hypothesis requiring further combinatorial validation in MSS-CRC-relevant systems.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149375802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ZNF460–SNRPB–RDM1 splicing axis promotes clear cell renal cell carcinoma progression through regulation of DNA damage repair ZNF460-SNRPB-RDM1剪接轴通过调控DNA损伤修复促进透明细胞肾细胞癌的进展
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-11 DOI: 10.1007/s10495-026-02467-z
Kang Liu, Yao Yao, Han Xiang, Yang Wang, Chunchao Jiang, Lixia Wang, Jin Zhu
{"title":"ZNF460–SNRPB–RDM1 splicing axis promotes clear cell renal cell carcinoma progression through regulation of DNA damage repair","authors":"Kang Liu,&nbsp;Yao Yao,&nbsp;Han Xiang,&nbsp;Yang Wang,&nbsp;Chunchao Jiang,&nbsp;Lixia Wang,&nbsp;Jin Zhu","doi":"10.1007/s10495-026-02467-z","DOIUrl":"10.1007/s10495-026-02467-z","url":null,"abstract":"<div><p>Small nuclear ribonucleoprotein polypeptide B (SNRPB) is one of the core proteins of the spliceosome. Although its role in spliceosome assembly has been well - established, its carcinogenic potential has just begun to be revealed. We found that its expression is significantly increased in clear cell renal cell carcinoma (ccRCC) and is associated with a poor prognosis. Mechanistically, this study reveals a carcinogenic axis centered around abnormal RNA splicing: the ZNF460–SNRPB–RDM1 axis. The upstream transcription factor ZNF460 transcriptionally activates SNRPB through a predicted ZNF460-responsive element in the SNRPB promoter, leading to the abnormally high expression of the core spliceosome protein SNRPB in ccRCC. Excessive SNRPB interferes with the precise splicing of RDM1 pre-mRNA, resulting in the dysregulated expression of functional RDM1 protein. As a protein implicated in DNA damage repair and homologous recombination-associated processes, changes in the expression level of RDM1 alter the sensitivity of ccRCC cells to the PARP inhibitor olaparib. Therefore, this axis is not only a newly discovered driver of ccRCC invasiveness and drug resistance but may also be a new therapeutic target.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149375801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma 在Burkitt淋巴瘤中,Carrimycin抑制TCF3-BCR信号轴并诱导DNA氧化损伤
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-11 DOI: 10.1007/s10495-026-02477-x
Qingfeng Xue, Juan Ye, Herui Wang, Han Ye, Yaping Zhang, Shuran Chen, Zhengping Zhuang
{"title":"Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma","authors":"Qingfeng Xue,&nbsp;Juan Ye,&nbsp;Herui Wang,&nbsp;Han Ye,&nbsp;Yaping Zhang,&nbsp;Shuran Chen,&nbsp;Zhengping Zhuang","doi":"10.1007/s10495-026-02477-x","DOIUrl":"10.1007/s10495-026-02477-x","url":null,"abstract":"<div><p>Burkitt lymphoma (BL) is a highly aggressive B-cell malignancy with poor outcomes in relapsed or central nervous system (CNS)-involved cases. This study investigates the antitumor mechanism of Carrimycin, a genetically engineered macrolide antibiotic, in BL. In vitro assays demonstrated that Carrimycin exerts potent, dose-dependent cytotoxicity, inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis. Mechanistically, it triggered the generation of reactive oxygen species (ROS), leading to DNA damage. Transcriptomic profiling and molecular assays revealed that Carrimycin binds to the transcription factor 3 (TCF3), causing a collapse of the tonic B-cell receptor (BCR) signaling pathway. Genetic knockdown of TCF3 partially rescued BL cells from Carrimycin-induced cytotoxicity, confirming this molecular dependency. In vivo, Carrimycin suppressed tumor burden and prolonged survival in both subcutaneous and intracranial models with a favorable safety profile. In conclusion, Carrimycin is a therapeutic agent that targets TCF3 to inhibit the tonic BCR signaling axis while simultaneously driving lethal oxidative stress. Its systemic and intracranial efficacy positions Carrimycin as a highly promising candidate for clinical translation in high-risk and CNS-involved BL.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s10495-026-02477-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149375800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the Nrf2-SIRT1 axis abrogates metabolic plasticity and sensitizes breast cancer to oxidative stress 靶向Nrf2-SIRT1轴可消除代谢可塑性并使乳腺癌对氧化应激敏感
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-11 DOI: 10.1007/s10495-026-02471-3
Chen-Chun Liu, Kai-Hsi Lu, Jhih-Pu Syu, Hsiu-Ni Kung
{"title":"Targeting the Nrf2-SIRT1 axis abrogates metabolic plasticity and sensitizes breast cancer to oxidative stress","authors":"Chen-Chun Liu,&nbsp;Kai-Hsi Lu,&nbsp;Jhih-Pu Syu,&nbsp;Hsiu-Ni Kung","doi":"10.1007/s10495-026-02471-3","DOIUrl":"10.1007/s10495-026-02471-3","url":null,"abstract":"<div><h3>Background</h3><p>Hyperactivation of the antioxidant transcription factor Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) strongly correlates with tumor progression and poor prognosis in aggressive breast cancers. While Nrf2 is known to influence tumor metabolism, the precise molecular mechanism by which it orchestrates “metabolic plasticity”, the ability to flexibly fulfill immense bioenergetic demands, remains largely elusive.</p><h3>Methods and results</h3><p>Integrating clinical dataset analysis with in vitro genetic manipulation (MCF7 and MDA-MB-231), we confirmed Nrf2 as a core driver of breast cancer tumorigenesis. Metabolic profiling revealed that Nrf2 confers robust metabolic plasticity by concurrently upregulating both oxidative phosphorylation (OXPHOS) and glycolysis, resulting in an ATP production surge. Mechanistically, Nrf2 upregulates the expression of SIRT1, which serves as an indispensable hub for this dual metabolic enhancement. Pharmacological inhibition (using NAM or EX527) or genetic knockdown of SIRT1 effectively dismantled the Nrf2-driven metabolic advantage, drastically reducing ATP levels and suppressing colony formation. Furthermore, we uncovered an additive cytotoxic effect where combining SIRT1 inhibition with oxidative stress (H<sub>2</sub>O<sub>2</sub>) severely impaired the bioenergetic reserve and disrupted redox balance, leading to a marked suppression of cancer cell survival and clonogenic capacity.</p><h3>Conclusion</h3><p>Our findings identify the Nrf2-SIRT1 axis as a master coordinator of metabolic plasticity in breast cancer. Repurposing SIRT1 inhibitors to disrupt this bioenergetic adaptation provides a potential, mechanism-guided rationale to sensitize therapy-resistant and Nrf2-hyperactivated breast cancer cells to oxidative stress in preclinical models.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149375810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disturbed flow-induced mitochondrial remodeling regulates endothelial cell death in atherosclerosis 血流紊乱诱导的线粒体重塑调节动脉粥样硬化中内皮细胞的死亡
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-11 DOI: 10.1007/s10495-026-02476-y
Lanqing Hu, Changxin Sun, Jingyi Song, Ziyi Xu, Xiaoya Li, Xiaonan Zhang, Kaidong Zhou, Min Wu, Longtao Liu
{"title":"Disturbed flow-induced mitochondrial remodeling regulates endothelial cell death in atherosclerosis","authors":"Lanqing Hu,&nbsp;Changxin Sun,&nbsp;Jingyi Song,&nbsp;Ziyi Xu,&nbsp;Xiaoya Li,&nbsp;Xiaonan Zhang,&nbsp;Kaidong Zhou,&nbsp;Min Wu,&nbsp;Longtao Liu","doi":"10.1007/s10495-026-02476-y","DOIUrl":"10.1007/s10495-026-02476-y","url":null,"abstract":"<div><p>Endothelial cell death is a critical event contributing to the initiation and progression of atherosclerosis (AS). Atherosclerotic lesions preferentially develop at arterial bifurcations and curvatures, where endothelial cells are continuously exposed to disturbed flow and experience pathological mechanotransduction. Although apoptosis, pyroptosis, and ferroptosis have been implicated in endothelial injury under adverse h​aemodynamic conditions, how biomechanical stimuli are converted into specific cell death responses remains incompletely understood. Emerging evidence indicates that distinct disturbed-flow patterns and exposure conditions can elicit context-dependent mitochondrial remodeling, involving changes in network dynamics, subcellular positioning, quality control, and redox homeostasis. In this review, we discuss how haemodynamic stimuli may regulate endothelial cell death in AS through mitochondrial remodeling, while emphasizing that mitochondrial responses vary with the magnitude, directionality, and duration of flow. We further discuss emerging therapeutic strategies aimed at reducing endothelial cell death under adverse haemodynamic conditions by restoring atheroprotective flow, modulating endothelial mechanotransduction, and preserving mitochondrial homeostasis, thereby providing new perspectives for the prevention and treatment of atherosclerotic cardiovascular disease.</p><h3>Graphic abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 12","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149375803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nr1d1 regulates ER-mitochondria interactions and calcium transfer, and muscle cell apoptosis Nr1d1调节内质网线粒体相互作用、钙转运和肌肉细胞凋亡。
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-03 DOI: 10.1007/s10495-026-02466-0
Alexis Boulinguiez, Christian Duhem, Alicia Mayeuf-Louchart, Nadia Bendridi, Jérôme Kluza, Yasmine Sebti, Nicolas Barois, Elisabeth Werkmeister, Quentin Thorel, Justine Beauchamp, Stéphane Delhaye, Lise Ferri, Marie Couvelaere, Cécilia Bellengier, Mathilde Zecchin, Benoît Pourcet, Jennifer Rieusset, Bart Staels, Hélène Duez, Steve Lancel
{"title":"Nr1d1 regulates ER-mitochondria interactions and calcium transfer, and muscle cell apoptosis","authors":"Alexis Boulinguiez,&nbsp;Christian Duhem,&nbsp;Alicia Mayeuf-Louchart,&nbsp;Nadia Bendridi,&nbsp;Jérôme Kluza,&nbsp;Yasmine Sebti,&nbsp;Nicolas Barois,&nbsp;Elisabeth Werkmeister,&nbsp;Quentin Thorel,&nbsp;Justine Beauchamp,&nbsp;Stéphane Delhaye,&nbsp;Lise Ferri,&nbsp;Marie Couvelaere,&nbsp;Cécilia Bellengier,&nbsp;Mathilde Zecchin,&nbsp;Benoît Pourcet,&nbsp;Jennifer Rieusset,&nbsp;Bart Staels,&nbsp;Hélène Duez,&nbsp;Steve Lancel","doi":"10.1007/s10495-026-02466-0","DOIUrl":"10.1007/s10495-026-02466-0","url":null,"abstract":"<div><p>The Endoplasmic Reticulum (ER) and mitochondria interact within specific structures called Mitochondria–ER Contact sites (MERCs). MERCs are involved in calcium exchange and apoptosis. However, factors controlling MERC formation and functions are not fully identified. Since the nuclear receptor Nr1d1 (also known as Rev-erbα) modulates both mitochondrial function and reticular calcium homeostasis in skeletal muscle, we explored whether Nr1d1 could also impact MERC formation and as such modulate calcium fluxes and apoptosis of muscle cells upon ER stress.</p><p>Here, we observe that Nr1d1 overexpression in C2C12 muscle cells and human myotubes increases MERC formation, favoring calcium transfer from the ER toward mitochondria. Upon tunicamycin-induced ER stress, Nr1d1 overexpression causes greater calcium influx into mitochondria, subsequently triggering a deeper reduction in mitochondrial efficiency and exacerbating apoptosis. Pharmacological inhibition of MERCs formation partly abolishes Nr1d1 effects on ER stress-induced calcium transfer and apoptosis.</p><p>These findings identify Nr1d1 as a new modulator of MERCs in muscle cells.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 11","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitoxyperilysis and mitochondrial quality control in Parkinson’s disease: emerging links to autophagy and neuronal death 帕金森病的线粒体坏死和线粒体质量控制:与自噬和神经元死亡的新联系
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-03 DOI: 10.1007/s10495-026-02465-1
Xinghua Tian, Biao Zhang, Jianshe Wei
{"title":"Mitoxyperilysis and mitochondrial quality control in Parkinson’s disease: emerging links to autophagy and neuronal death","authors":"Xinghua Tian,&nbsp;Biao Zhang,&nbsp;Jianshe Wei","doi":"10.1007/s10495-026-02465-1","DOIUrl":"10.1007/s10495-026-02465-1","url":null,"abstract":"<div><p>Parkinson’s disease (PD) is the second‑most prevalent central‑nervous‑system neurodegenerative disorder, pathologically characterized by progressive midbrain dopaminergic neuron loss and α‑synuclein‑aggregated Lewy bodies. Impaired mitophagy‑autophagy‑lysosomal quality control is a well‑documented upstream feature of PD; however, its characterization as a core causal driver—and how, or whether, mitophagy insufficiency is converted into irreversible dopaminergic neuronal death—remains incompletely resolved and lacks direct human evidence. Mitoxyperilysis is a recently described non‑caspase‑dependent lytic regulated cell‑death pathway. It can be triggered by combined innate‑immune activation and cellular metabolic disturbance, featuring mitochondrial oxidative stress, stable mitochondria‑plasma‑membrane anchoring and focal lipid‑peroxidation‑driven membrane rupture under the primary regulatory influence of the mTORC2-RhoA-cytoskeleton axis, a regulatory role established primarily in non-PD innate-immune and metabolic stress models. Mitophagy deficiency cannot directly initiate mitoxyperilysis but increases neuronal susceptibility by enabling persistent accumulation of ROS‑generating damaged mitochondria. This review summarizes mitoxyperilysis’s core features, regulatory cascades and detection approaches, focusing on its bidirectional crosstalk with the mitophagy‑autophagy‑lysosomal system. We discuss how PD‑associated genetic variants, α‑synuclein aggregation and neuroinflammation disrupt mitophagy‑lysosomal homeostasis and may predispose dopaminergic neurons to mitoxyperilysis‑related injury. We overview pre‑clinical therapeutic candidates and potential biomarkers, and consider plausible links to other neurodegenerative diseases, peripheral pathology and aging. Critical caveats are highlighted: most supporting data derive from cell and animal models, and unambiguous evidence for bona‑fide mitoxyperilysis in human PD tissues remains absent. We outline translational bottlenecks and future priorities centred on autophagy‑mitophagy‑mitoxyperilysis signalling crosstalk, offering proposed mechanistic perspectives that may connect mitophagy-lysosomal dysfunction to neuronal demise, a causal linkage that has not yet been directly demonstrated in human PD, together with conceptual considerations for PD drug discovery and early intervention.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 11","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell-specific responses to copper stress and cuproptosis in renal fibrosis 肾纤维化对铜应激和铜增生的细胞特异性反应。
IF 9 2区 生物学
Apoptosis Pub Date : 2026-11-03 DOI: 10.1007/s10495-026-02470-4
Xiaotong Wang, Xuqi Sun, Xin Yao, Yunjia Jiang, Weiqun Liu, Dechun Geng, Ping Xia, Minggang Wei
{"title":"Cell-specific responses to copper stress and cuproptosis in renal fibrosis","authors":"Xiaotong Wang,&nbsp;Xuqi Sun,&nbsp;Xin Yao,&nbsp;Yunjia Jiang,&nbsp;Weiqun Liu,&nbsp;Dechun Geng,&nbsp;Ping Xia,&nbsp;Minggang Wei","doi":"10.1007/s10495-026-02470-4","DOIUrl":"10.1007/s10495-026-02470-4","url":null,"abstract":"<div><p>Renal fibrosis is a common pathological feature of progressive chronic kidney disease (CKD). Its development involves persistent injury to resident renal cells, inflammation, myofibroblast activation, and excessive accumulation of extracellular matrix (ECM). Renal fibrosis is not driven by a single cell type but results from sustained interactions among resident renal cells, infiltrating immune cells, matrix-producing fibroblasts, and other cell populations. Within this multicellular context, cuproptosis, a recently described form of copper-dependent cell death, may contribute to the onset and progression of renal fibrosis by amplifying inflammation, fostering a profibrotic microenvironment, and promoting ECM deposition during kidney injury. Elevated intracellular copper alone, however, is insufficient to trigger cuproptosis. Cellular susceptibility also depends on metabolic state, mitochondrial function, and mitochondrial protein lipoylation. Because renal cell types differ substantially in these biological features, the effects of cuproptosis-related stress are likely to vary across cell populations. This review aims to systematically elucidate the essential prerequisites underlying cuproptosis and its role in renal fibrosis from the perspective of cell type specificity. In particular, we highlight the heterogeneity of renal tubular epithelial cells, podocytes, endothelial cells, immune cells, and fibroblasts in terms of energy metabolism, reliance on mitochondrial function, copper-handling capacity, and protein lipoylation to discuss how these differences may give rise to distinct injury patterns and pathological consequences of cuproptosis-related stress. Finally, this review summarizes potential therapeutic strategies targeting copper homeostasis and cuproptosis-related stress to attenuate renal fibrosis, offering new directions for understanding the mechanisms of renal fibrosis and developing more cell-specific interventions.</p></div>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":"31 11","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书